Article Details

Roche gets FDA's Orphan Drug tag for pralsetinib in solid tumors (BPMC) | Seeking Alpha

Retrieved on: 2022-02-23 06:42:07

Tags for this article:

Click the tags to see associated articles and topics

Roche gets FDA's Orphan Drug tag for pralsetinib in solid tumors (BPMC) | Seeking Alpha. View article details on hiswai:

Excerpt

The U.S. Food and Drug Administration ((FDA)) has awarded Genentech, the U.S.-based unit of Swiss pharma giant Roche (RHHBY) (RHHBF), the Orphan ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up